Exactly
That will be the process if an initial foothold is obtained. They aren’t called break through initiatives for nothing.
OSL has to gain recognition in the market place and thus far that has not happened.
Will it happen ? and if so when ? are the vexing questions which only news from the company can answer.
They’ve certainly put the infrastructure in place and they are very active in all the right professional circles and forums but that all means nought if the product sits on the shelf and the cash at hand dwindles away.
To invest, to stay invested or to divest and move on is an individual choice that can’t be answered in a HC chat room.
Personally, I remain quietly confident and I think there is an accumulation process in play at the moment . I’m looking forward to it breaking 18c to provide a bit more confidence on that.
But I reserve the right to change my mind on that as circumstances might dictate.
- Forums
- ASX - By Stock
- OSL
- Ann: OncoSil receives Swiss regulatory approval
OSL
oncosil medical ltd
Add to My Watchlist
5.69%
!
$1.16

Ann: OncoSil receives Swiss regulatory approval, page-33
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M |
Open | High | Low | Value | Volume |
$1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9286 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 412 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9286 | 1.160 |
1 | 7500 | 1.080 |
2 | 19761 | 1.050 |
1 | 2500 | 1.030 |
1 | 550 | 1.020 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 412 | 1 |
1.200 | 8677 | 1 |
1.245 | 2418 | 1 |
1.250 | 46027 | 1 |
1.300 | 1500 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online